Clinical Trials Tracker

The following clinical trials represent a selection of key studies that are currently recruiting patients with prostate cancer for investigations of new treatments or new combinations for patients with prostate cancer. Each clinical trial description includes the NLM Identifier used by ClinicalTrials.gov. The information below can help urologists direct their eligible patients to one of these studies.

Read More ›

The following clinical trials represent a selection of key clinical trials that are currently recruiting patients with juvenile idiopathic arthritis (JIA) for inclusion in investigations of new therapies and new regimens of available therapies for patients with JIA. Each trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these trials. Read More ›

The following clinical trials represent a selection of key clinical trials that are currently recruiting patients with gout for inclusion in investigations of new therapies and regimens of available therapies for patients with gout. Each clinical trial description includes the NLM Identifier to be used as a reference for Clin icalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these clinical trials. Read More ›

The following clinical trials represent a selection of key clinical trials that are currently recruiting patients with ankylosis for inclusion in investigations of new therapies and new regimens of available therapies for patients with ankylosing rheumatic diseases. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their eligible patients to one of these clinical trials. Read More ›

The following trials represent a selection of key clinical trials that are currently recruiting patients with rheumatic diseases for inclusion in investigations of new therapies or new combinations of available therapies. Each trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. Read More ›

The following trials represent a selection of key clinical trials that are currently recruiting patients with prostate cancer for inclusion in investigations of new therapies or new combinations of available therapies for patients with prostate cancer. Read More ›

The following trials represent a selection of key clinical trials that are currently recruiting patients for inclusion in investigations of new therapies or new combinations of available therapies for patients with lung cancer. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their eligible patients to one of these clinical trials. Read More ›

The following trials represent a selection of key clinical trials that are currently recruiting patients with prostate cancer for inclusion in investigations of new therapies or new combinations of available therapies for patients with prostate cancer. Each trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their eligible patients to one of these clinical trials. Read More ›

The following trials represent a selection of key clinical trials that are currently recruiting patients with breast cancer for inclusion in investigations of new therapies for breast cancer. Each trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their appropriate patients to one of these clinical trials. Read More ›

The following clinical trials are currently recruiting patients with myelodysplastic syndrome for inclusion in a variety of studies targeting specific subpopulation of patients with this syndrome. Each trial description includes the NLM Identifier to use as a reference with ClinicalTrials.gov. The information below can help oncology practice managers and providers direct their appropriate patients to a specific clinical trial described here. Read More ›

Page 2 of 5

Urology Practice Management logo
Subscribe to Urology Practice Management

Stay up to date with urology news & updates by subscribing to receive the free UPM print publications or e‑Newsletters.

UPM e-Newsletter
UPM print publication